Evotec - Research never stops

Archive



Dec 01, 2006

PerkinElmer to Acquire Evotec Technologies

Nov 17, 2006

Evotec Initiates Second Phase II Clinical Trial with Insomnia Drug EVT 201

Nov 09, 2006

Evotec Reports Strong Q3 Growth

Oct 20, 2006

Evotec Technologies Installs plate::explorer(TM) and Opera(TM) for High Throughput Screening at the Genome Research Institute

Oct 16, 2006

Daiichi Pharmaceutical Selects Evotec as Partner for Medicinal Chemistry and Compound Profiling

Sep 28, 2006

Evotec Achieves Certificate of GMP Compliance from MHRA

Sep 21, 2006

Evotec Initiates Phase II Clinical Trial with EVT 201 for the Treatment of Insomnia

Sep 19, 2006

Evotec Appoints David Brister Chief Business Officer

Sep 13, 2006

Evotec Discontinues EVT 301 Development Programme

Aug 16, 2006

Evotec Reaches Second Milestone and Receives Success Payment in Alzheimer's Disease Collaboration with Takeda

Aug 11, 2006

Evotec Reports Encouraging Results for the First Half Year and Confirms Guidance

Aug 10, 2006

CHDI Selects Evotec as Strategic Drug Discovery Partner in the Search for Huntington Disease Treatments

Aug 08, 2006

Evotec Successfully Completes Phase I for Potential Alzheimer's Disease and Neuropathic Pain Treatment, EVT 101

Jul 24, 2006

Evotec Sells Single Molecule Detection Technology & IP Portfolio to Olympus

Jul 18, 2006

DAC Selects Evotec as Strategic Partner for a Drug Discovery Collaboration on the HSP90 Cancer Target

Jun 21, 2006

Evotec and Roche Form Global Alliance to Jointly Discover Novel Drugs

Jun 08, 2006

Evotec Announces Positive Phase I/II Clinical Trial Results with Insomnia Treatment EVT 201

May 11, 2006

Evotec Announces Q1 2006 Financial Results

Apr 27, 2006

Sankyo Selected Evotec as Assay Development and Screening Partner

Apr 25, 2006

Evotec Signs Two Significant Contracts with Roche

Apr 04, 2006

University of Cincinnati and Cincinnati Children's Hospital Medical Center Partner with Evotec to Enhance Drug Discovery

Mar 28, 2006

Evotec Announces Full Year 2005 Financial Results

Mar 10, 2006

Evotec and Boehringer Ingelheim Achieve Second Milestone in Joint Discovery Collaboration

Feb 14, 2006

Evotec and Apeiron Biologics to Discover Novel Pain Therapeutics

Feb 03, 2006

Evotec Successfully Completes Single Ascending Dose Component of Phase I Trial with EVT 101 for Alzheimer's Disease

Jan 17, 2006

Evotec and Boehringer Ingelheim Significantly Expand and Extend their Joint Drug Discovery Collaboration

Jan 09, 2006

Evotec Licenses Two Phase I Compounds with Disease Modifying Potential in Alzheimer's Disease